Are endoscopic or percutaneous biliary drainage effective forobstructive jaundice caused by hepatocellular carcinoma?

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 3, 2011, Pages 224-231

  Cho, Hyun Chin ^a   Lee, Jong Kyun ^a   Lee, Kwang Hyuck ^a   Lee, Kyu Taek ^a   Paik, Seungwoon ^a   Choo, Sung Wook ^a   Do, Young Soo ^a   Choo, In Wook ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

biliary drainage; hepatocellular carcinoma; obstructive jaundice

Indexed keywords

BILIRUBIN;

ADULT; ARTICLE; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CANCER THERAPY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

AGED; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; DRAINAGE; ENDOSCOPY; FEMALE; HUMANS; JAUNDICE, OBSTRUCTIVE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79951942814     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283436ff6     Document Type: Article

References (30)

1. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48 900 necropsies. Cancer 1954; 7:462-503.
2. Kappel DA, Miller DR. Primary hepatic carcinoma. A review of thirty-seven patients. Am J Surg 1972; 124:798-802.
3. Ihde DC, Sherlock P, Winawer SJ, Fortner JG. Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital. Am J Med 1974; 56:83-91.
4. Kew MC, Geddes EW. Hepatocellular carcinoma in rural southern African blacks. Medicine (Baltimore) 1982; 61:98-108. (Pubitemid 12158546)
5. Lau W, Leung K, Leung TW, Liew CT, Chan MS, Yu SC, et al. A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg 1997; 225:281-285. (Pubitemid 27131564)
6. Leow CK, Lau JWY. Management of specific tumour complications. In: Leong ASY, Liew CT, Lau JWY, Johnson PJ, editors. Hepatocellular carcinoma. Diagnosis, investigation and management. London, England: Arnold; 1999. pp. 193-203.
7. Okuda K. Clinical aspects of hepatocellular carcinoma, analysis of 134 cases. In: Okuda K, Petrs RL, editors. Hepatocellular carcinoma. New York, NY: John Wiley & Sons; 1976. pp. 387-436.
8. Lin TY. Primary malignant tumours. In: Bockus H, editor. Gastroenterology. 3rd ed. Philadelphia: W.B. Saunders; 1976. pp. 522-533.
9. Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N, Nakashima T. Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer 1982; 49:2144-2147. (Pubitemid 12100748)
10. Lee NW, Wong KP, Siu KF, Wong J. Cholangiography in hepatocellular carcinoma with obstructive jaundice. Clin Radiol 1984; 35:119-123. (Pubitemid 14152678)
11. Kew MC, Paterson AC. Unusual clinical presentations of hepatocellular carcinoma. Trop Gastroenterol 1985; 6:10-22.
12. Lai EC, Ng IO, Ng MM, Lok AS, Tam PC, Fan ST, et al. Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 1990; 11:815-818. (Pubitemid 20191388)
13. Lau WY, Leung KL, Leung TW, Ho S, Chan M, Liew CK, et al. Obstructive jaundice secondary to hepatocellular carcinoma. Surg Oncol 1995; 4:303-308. (Pubitemid 26261010)
14. Huang JF, Wang LY, Lin ZY, Chen SC, Hsieh MY, Chuang WL, et al. Incidence and clinical outcome of icteric type hepatocellular carcinoma. J Gastroenterol Hepatol 2002; 17:190-195.
15. Hong HP, Kim SK, Seo TS. Percutaneous metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma. J Vasc Interv Radiol 2008; 19:748-754.
16. Chen MF, Jan YY, Jeng LB, Hwang TL, Wang CS, Chen SC. Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases. Cancer 1994; 73:1335-1340.
17. Okazaki M, Mizuta A, Hamada N, Kawamura N, Nakao K, Kikuchi T, et al. Hepatocellular carcinoma with obstructive jaundice successfully treated with a self-expandable metallic stent. J Gastroenterol 1998; 33:886-890. (Pubitemid 29271555)
18. Martin JA, Slivka A, Rabinovitz M, Carr BI, Wilson J, Silverman WB. ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't? Dig Dis Sci 1999; 44:1298-1302. (Pubitemid 29404288)
19. Matsueda K, Yamamoto H, Umeoka F, Ueki T, Matsumura T, Tezen T, et al. Effectiveness of endoscopic biliary drainage for unresectable hepatocellular carcinoma associated with obstructive jaundice. J Gastroenterol 2001; 36:173-180. (Pubitemid 32285075)
20. Lee JW, Han JK, Kim TK, Choi BI, Park SH, Ko YH, et al. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors. Cardiovasc Intervent Radiol 2002; 25:176-179. (Pubitemid 36919639)
21. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 4th ed. Tokyo: Kanehara; 2000.
22. Nakao N, Ishikura R, Miura K, Takahashi H, Miura T. Transcatheter arterial embolization in hepatoma complicated with obstructive jaundice. Cardiovasc Intervent Radiol 1987; 10:40-42. (Pubitemid 17019155)
23. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-1261.
24. Yoshioka T, Uchida H, Kitano S, Makutani S, Maeda M, Taoka T, et al. Long-term palliative treatment of hepatocellular carcinoma extending into the portal vein and bile duct by chemoembolization and metallic stenting. Cardiovasc Intervent Radiol 1997; 20:390-393. (Pubitemid 27398415)
25. Lau WY, Ho S, Leung TW, Chan M, Ho R, Johnson PJ, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 1998; 40:583-592. (Pubitemid 28104228)
26. Lau WY, Yu SC, Lai EC, Leung TW. Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg 2006; 202:155-168. (Pubitemid 41831485)
27. Kubota Y, Seki T, Kunieda K, Nakahashi Y, Tani K, Nakatani S, et al. Biliary endoprosthesis in bile duct obstruction secondary to hepatocellular carcinoma. Abdom Imaging 1993; 18:70-75. (Pubitemid 23167155)
28. Ducreux M, Liguory C, Lefebvre JF, Ink O, Choury A, Fritsch J, et al. Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 1992; 37:778-783.
29. Hu J, Pi Z, Yu MY, Li Y, Xiong S. Obstructive jaundice caused by tumor emboli from hepatocellular carcinoma. Am Surg 1999; 65:406-410. (Pubitemid 29200898)
30. Lauffer JM, Mai G, Berchtold D, Curti CG, Triller J, Baer HU. Multidisciplinary approach to palliation of obstructive jaundice caused by a central hepatocellular carcinoma. Dig Surg 1999; 16:531-536. (Pubitemid 30072167)